Delivery Order SPE2DB22D2206-SPE2DB23FJL75
Award Date 7/28/23
Potential Completion Date 7/31/23
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,363 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 4561401397 units of the specified medication. Performance will take place in Conshohocken, Pennsylvania over a three-day period from July 3 to July 5, 2023. As the DLA supports military treatment...
- The Defense Logistics Agency awarded a $18,443.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 162 milligram/0.9 milliliter syringes of Actemra. Actemra is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The place of performance for the delivery order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is brief, spanning just one day from September 19, 2023 through...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,646 to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements by September 14, 2023. The Defense Logistics Agency functions to support America's armed forces by procuring their necessary...
- The Defense Logistics Agency awarded a $11,519.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 162 milligrams per 0.9 milliliter syringes of Actemra. Actemra is a brand name biologic medication used to treat conditions such as rheumatoid arthritis. The place of performance for this contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 23, 2023 through August 24, 2023. No major...
- The Defense Logistics Agency awarded a $5,532 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The single delivery order is for pharmaceutical products to support Department of Defense health programs and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by August 28, 2023. No set aside designation or subcontractors were identified for this small purchase to meet short-term DLA requirements for an...
- The Defense Logistics Agency awarded a delivery order valued at $7,194.60 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used in the treatment...
- The Defense Logistics Agency (DLA) awarded a $7,362.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 162 mg/0.9 mL Actemra syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfilled this delivery order under its...
- The Defense Logistics Agency awarded a $5,198.08 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 4561391614 ACTEMRA 162 MG/0.9 ML SYRINGES. The syringes will be delivered to a location in Conshohocken, Pennsylvania between June 30 and July 3, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense, this delivery order was likely placed to supply pharmaceutical products in...
- The Defense Logistics Agency awarded a delivery order valued at $8,134.65 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. This firm fixed-price, non-set-aside delivery order was awarded on January 6, 2026, with a completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used primarily for rheumatoid arthritis and other inflammatory conditions, making this a...
- The Defense Logistics Agency awarded a $2,877.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a pharmaceutical delivery to be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this a...